GABELLI FUNDS LLC recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
Gabelli Funds LLC is a private investment management company that was founded in 1980. Its parent company, GAMCO Investors, which it still acts as a subsidiary under, was founded in 1976 by Mario Gabelli (Trades, Portfolio). The company would have its first institutional mandate in 1978 and become the top asset manager of CDA investment technologies in 1982. The company would grow and enter the mutual fund business in 1986, continuing to expand and launching its growth fund in 1987 and value fund in 1989. In the 1990s, the company would begin focusing on international growth and launch its global series in 1994. In 1997, the Gabelli mutual fund series would be ranked as the top mutual fund family by Mutual Funds Magazine. The parent company would have its IPO in 199, allowing the company to increase its capital and facilitate its growth to be able to open its London office in 2001. Gabelli Funds currently has over $26.7 billion in total assets under management that is spread across 31 accounts held, averaging to over $860 million each. Although its total number of accounts held has remained relatively steady within the past five years, its total assets under management has increased from $11.4 billion in 2010 to over twice that at its current amount. The company currently has 49 employees with its headquarters in Rye, New York, although it also has offices in Bannockburn, Illinois; Minneapolis, Minnesota; and Yardley, Pennsylvania. Almost all of its clients are investment companies and Gabelli Funds provides equity, fixed income, balanced mutual fund, and money market management services. Most of its assets are allocated in the services sector, which alone makes up over a quarter of its allocated assets, and it also invests in the utilities, financial, basic materials, technology, and health care sectors, among others, in order of amount allocated. Some of the available mutual funds include the ABC Fund, Capital Asset Fund, Focus Five Fund, SRI Fund, Value 25 Fund, and GI Rising Inc & Div.
As of the latest 13F report, the guru’s equity portfolio contained 1140 stocks valued at a total of $12.66Bil. The top holdings were NEE(1.97%), DE(1.36%), and MA(1.33%).
According to GuruFocus data, these were GABELLI FUNDS LLC’s top five trades of the quarter.
Alleghany Corp
The guru sold out of their 82,434-share investment in NYSE:Y. Previously, the stock had a 0.58% weight in the equity portfolio. Shares traded for an average price of $843.86 during the quarter.
On 02/15/2023, Alleghany Corp traded for a price of $847.79 per share and a market cap of $11.41Bil. The stock has returned 27.62% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 7 out of 10.
In terms of valuation, Alleghany Corp has a price-earnings ratio of 33.43, a price-book ratio of 1.44, a price-earnings-to-growth (PEG) ratio of 1.49, a EV-to-Ebitda ratio of 13.62 and a price-sales ratio of 0.99.
The price-to-GF Value ratio is 0.96, earning the stock a GF Value rank of 5.
Zendesk Inc
The guru sold out of their 608,807-share investment in NYSE:ZEN. Previously, the stock had a 0.39% weight in the equity portfolio. Shares traded for an average price of $76.47 during the quarter.
On 02/15/2023, Zendesk Inc traded for a price of $77.48 per share and a market cap of $9.63Bil. The stock has returned -20.30% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 3 out of 10.
In terms of valuation, Zendesk Inc has a price-book ratio of 27.67, a EV-to-Ebitda ratio of -45.44 and a price-sales ratio of 5.97.
The price-to-GF Value ratio is 0.51, earning the stock a GF Value rank of 8.
Nielsen Holdings PLC
The guru sold out of their 1,185,165-share investment in NYSE:NLSN. Previously, the stock had a 0.28% weight in the equity portfolio. Shares traded for an average price of $27.94 during the quarter.
On 02/15/2023, Nielsen Holdings PLC traded for a price of $27.98 per share and a market cap of $10.07Bil. The stock has returned 43.76% over the past year.
GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 6 out of 10.
In terms of valuation, Nielsen Holdings PLC has a price-earnings ratio of 19.03, a price-book ratio of 2.90, a price-earnings-to-growth (PEG) ratio of 14.85, a EV-to-Ebitda ratio of 11.37 and a price-sales ratio of 2.86.
The price-to-GF Value ratio is 1.25, earning the stock a GF Value rank of 1.
Global Blood Therapeutics Inc
The guru sold out of their 432,378-share investment in NAS:GBT. Previously, the stock had a 0.25% weight in the equity portfolio. Shares traded for an average price of $68.48999999999999 during the quarter.
On 02/15/2023, Global Blood Therapeutics Inc traded for a price of $68.48999999999999 per share and a market cap of $4.62Bil. The stock has returned 165.36% over the past year.
GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 1 out of 10.
In terms of valuation, Global Blood Therapeutics Inc has a price-book ratio of 38.94, a EV-to-Ebitda ratio of -16.54 and a price-sales ratio of 18.82.
The price-to-GF Value ratio is 0.85, earning the stock a GF Value rank of 6.
ChemoCentryx Inc
The guru sold out of their 532,080-share investment in NAS:CCXI. Previously, the stock had a 0.23% weight in the equity portfolio. Shares traded for an average price of $51.92 during the quarter.
On 02/15/2023, ChemoCentryx Inc traded for a price of $51.99 per share and a market cap of $3.74Bil. The stock has returned 49.18% over the past year.
GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 2 out of 10.
In terms of valuation, ChemoCentryx Inc has a price-book ratio of 15.68, a EV-to-Ebitda ratio of -27.52 and a price-sales ratio of 98.47.
The price-to-GF Value ratio is 1.04, earning the stock a GF Value rank of 5.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
